Sign In
Buy NTCT
$42.30
-1.13 (-2.60%)
At Close: Jun 03, 2026
NETGEAR, Inc. (NTGR) Q3 Earnings and Revenues Surpass Estimates
09:35pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
NETGEAR, Inc. (NTGR) delivered earnings and revenue surprises of 162.50% and 2.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
NETSCOUT to Report Q2 FY'23 Financial Results on October 27th
08:30am, Wednesday, 12'th Oct 2022
WESTFORD, Mass.
Strength Seen in Intrusion Inc. (INTZ): Can Its 14.4% Jump Turn into More Strength?
07:51am, Monday, 19'th Sep 2022 Zacks Investment Research
Intrusion Inc. (INTZ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price incre
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
09:14am, Tuesday, 13'th Sep 2022 Benzinga
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
InMed Pharmaceuticals Inc. (NASDAQ: INM)
NetScout (NTCT) Moves 9.4% Higher: Will This Strength Last?
07:36am, Tuesday, 13'th Sep 2022 Zacks Investment Research
NetScout (NTCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
NIO, Lucid Group And Other Big Gainers From Monday
07:01am, Tuesday, 13'th Sep 2022 Benzinga
U.S. stocks closed higher with the Dow Jones surging more than 200 points on Monday. Here is the list of some big stocks moving higher in the previous session.
Ventyx Biosciences, Inc. (NASDAQ: VTYX
NetScout (NTCT) Moves 9.4% Higher: Will This Strength Last?
05:16am, Tuesday, 13'th Sep 2022
NetScout (NTCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
04:45pm, Monday, 12'th Sep 2022 Benzinga
Gainers
Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
NeuroBo Phar
NetScout Systems, Inc. (NTCT) CEO Anil Singhal on Q1 2023 Earnings Call Transcript
10:55pm, Friday, 05'th Aug 2022
NetScout Systems, Inc. (NASDAQ:NTCT ) Q1 2023 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Tony Piazza - VP, Corporate Finance Anil Singhal - President and CEO Michael Szaba
NetScout Systems (NTCT) Q1 2023 Earnings Call Transcript
03:30pm, Thursday, 04'th Aug 2022 The Motley Fool
NTCT earnings call for the period ending June 30, 2022.
NetScout Systems (NTCT) Beats Q1 Earnings and Revenue Estimates
01:05pm, Thursday, 04'th Aug 2022 Zacks Investment Research
NetScout (NTCT) delivered earnings and revenue surprises of 9.09% and 1.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
NETGEAR, Inc. (NTGR) Reports Q2 Loss, Tops Revenue Estimates
09:45pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
NETGEAR, Inc. (NTGR) delivered earnings and revenue surprises of 20.83% and 6.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
NETSCOUT to Report Q1 FY'23 Financial Results on August 4th
09:43am, Wednesday, 13'th Jul 2022
WESTFORD, Mass.--(BUSINESS WIRE)--NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) plans to announce its first-quarter fiscal year 2023 financial results for the period ended June 30, 2022, on Thursday, August 4
Diamond Hill Long-Short Fund 2022 Market Commentary
04:44am, Wednesday, 08'th Jun 2022 Seeking Alpha
The Diamond Hill Long-Short Fund'S returns were just about flat to slightly positive in Q1. Click here to read the full fund letter.
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
02:02pm, Tuesday, 31'st May 2022 Benzinga
Upgrades
Guggenheim upgraded the previous rating for Novo Nordisk A/S (NYSE:NVO) from Neutral to Buy. Novo Nordisk earned $0.94 in the first quarter, compared to $0.88 in the year-ago quarter. The sto
